AEGEAN Trial: The Role of Perioperative Durvalumab in NSCLC
Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Alan Bryce, MD
PeerRishi Sekar, MD
PeerNadia Harbeck, MD, PhD
PeerNadia Harbeck, MD, PhD
PeerNadia Harbeck, MD, PhD
PeerNadia Harbeck, MD, PhD
PeerEgbert Smit, MD
PeerAddressing Treatment Gaps in Anemia Among MDS Patients
Cholangiocarcinoma: Treatment with Targeted Therapies
Advancements in Pretreated HR+/HER2- Metastatic Breast Cancer
Advancements in Pretreated Metastatic Triple-Negative Breast Cancer
Advances in HR-MDS: Updates in Diagnosis, Risk Assessment, and Current Standard of Care Challenges
Rami Komrokji, MD
Peer